EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment

K P Ameya, P P Ashikha Shirin Usman, Durairaj Sekar

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2025

DOI: 10.1016/j.bbagrm.2025.195091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2025. Verfasst von K P Ameya und 2 weiteren Autor:innen. Beteiligte Einrichtung: RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai 600…. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Vascular Endothelial Growth Factor A, Neovascularization, Pathologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 121 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer progression is a multifaceted process influenced by complex interactions within the tumor microenvironment (TME). Central to these dynamics are Vascular Endothelial Growth Factor (VEGF) signalling and microRNA (miRNA) modulation, both of which play critical roles in tumor growth and angiogenesis. VEGF is essential for promoting blood vessel formation; however, its splice variant, VEGF165b, acts as an anti-angiogenic factor, presenting a paradox challenging conventional cancer therapies. Meanwhile, miRNAs regulate gene expression that significantly impacts tumor behaviour by targeting various mRNAs involved in signalling pathways. The interplay between VEGF and miRNAs opens new avenues for targeted therapies designed to disrupt the networks supporting tumor growth. Additionally, the concept of exploiting the unique properties of VEGF splice variants is being explored to develop novel treatments that enhance anti-angiogenic effects while minimizing side effects. Understanding this is crucial for advancing personalized therapies that can effectively address the challenges posed by tumor adaptability and resistance mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsVascular Endothelial Growth Factor ANeovascularization, PathologicHumansTumor MicroenvironmentGene Expression Regulation, NeoplasticAnimalsSignal Transduction

Stichwörter der Autor:innen

Tumor microenvironmentVEGFVEGF165bVasculogenic mimicrycancermiRNA

Substanzen

MicroRNAsVascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai 600077, India.
  • RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai 600077, India. Electronic address: duraimku@gmail.com.

Zitieren

APA

Ameya, K. P., Ashikha Shirin Usman, P. P., & Sekar, D. (2025). Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. https://doi.org/10.1016/j.bbagrm.2025.195091

Vancouver

Ameya KP, Ashikha Shirin Usman PP, Sekar D. Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2025. doi:10.1016/j.bbagrm.2025.195091

BibTeX
@article{Ameya2025,
  author = {Ameya, K P and Ashikha Shirin Usman, P P and Sekar, Durairaj},
  title = {Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment},
  journal = {Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms},
  year = {2025},
  doi = {10.1016/j.bbagrm.2025.195091}
}
Kostenlos starten →